475 related articles for article (PubMed ID: 26292963)
21. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
[TBL] [Abstract][Full Text] [Related]
22. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.
Margheri F; Manetti M; Serratì S; Nosi D; Pucci M; Matucci-Cerinic M; Kahaleh B; Bazzichi L; Fibbi G; Ibba-Manneschi L; Del Rosso M
Arthritis Rheum; 2006 Dec; 54(12):3926-38. PubMed ID: 17133606
[TBL] [Abstract][Full Text] [Related]
23. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins.
Gu C; Yoshida Y; Livet J; Reimert DV; Mann F; Merte J; Henderson CE; Jessell TM; Kolodkin AL; Ginty DD
Science; 2005 Jan; 307(5707):265-8. PubMed ID: 15550623
[TBL] [Abstract][Full Text] [Related]
24. Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells.
Romano E; Rosa I; Fioretto BS; Giuggioli D; Manetti M; Matucci-Cerinic M
Rheumatology (Oxford); 2023 Feb; 62(SI):SI125-SI137. PubMed ID: 35900177
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
26. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
[TBL] [Abstract][Full Text] [Related]
27. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
[TBL] [Abstract][Full Text] [Related]
28. Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis.
Romano E; Rosa I; Fioretto BS; Matucci-Cerinic M; Manetti M
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888144
[TBL] [Abstract][Full Text] [Related]
29. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys.
Watakabe A; Ohsawa S; Hashikawa T; Yamamori T
J Comp Neurol; 2006 Nov; 499(2):258-73. PubMed ID: 16977617
[TBL] [Abstract][Full Text] [Related]
30. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
Giusti B; Serratì S; Margheri F; Papucci L; Rossi L; Poggi F; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Matucci-Cerinic M; Abbate R; Fibbi G; Del Rosso M
Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
[TBL] [Abstract][Full Text] [Related]
31. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin.
Mackiewicz Z; Sukura A; Povilenaité D; Ceponis A; Virtanen I; Hukkanen M; Konttinen YT
Clin Exp Rheumatol; 2002; 20(5):641-6. PubMed ID: 12412194
[TBL] [Abstract][Full Text] [Related]
32. A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems.
Romano E; Rosa I; Fioretto BS; Guiducci S; Manetti M; Matucci-Cerinic M
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):133-140. PubMed ID: 31025932
[TBL] [Abstract][Full Text] [Related]
33. Endothelial dysfunction in systemic sclerosis.
Altorok N; Wang Y; Kahaleh B
Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
[TBL] [Abstract][Full Text] [Related]
34. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1.
Toyofuku T; Yabuki M; Kamei J; Kamei M; Makino N; Kumanogoh A; Hori M
EMBO J; 2007 Mar; 26(5):1373-84. PubMed ID: 17318185
[TBL] [Abstract][Full Text] [Related]
35. RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.
Sun Y; Liu CH; Wang Z; Meng SS; Burnim SB; SanGiovanni JP; Kamenecka TM; Solt LA; Chen J
FASEB J; 2017 Oct; 31(10):4492-4502. PubMed ID: 28646017
[TBL] [Abstract][Full Text] [Related]
36. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
37. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
[TBL] [Abstract][Full Text] [Related]
38. A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Exp Dermatol; 2015 Feb; 24(2):127-32. PubMed ID: 25421497
[TBL] [Abstract][Full Text] [Related]
39. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis.
Rosato E; Borghese F; Pisarri S; Salsano F
J Rheumatol; 2009 Oct; 36(10):2257-63. PubMed ID: 19684154
[TBL] [Abstract][Full Text] [Related]
40. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L
J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
